Drugs / liposomal lidocaine
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01006187 Comparator | Oct → Nov 2009 | anxiety | The Hospital for Sick Children | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT02771600 Comparator | Jun → Sep 2018 | autoimmune disease, immunodeficiency disease | St. Justine's Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | liposomal lidocaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01006187 ↗ |
| Known as | Maxilene | “Maxilene® topical anaesthetic cream will be applied 30 minutes before the needle-related procedure on the insertion site” NCT02771600 ↗ |
| Route | Topical | “topical anesthesia using liposomal lidocaine to:” PMID 20483194 ↗ May 2010 |